InvestorsHub Logo
Followers 8
Posts 357
Boards Moderated 0
Alias Born 07/30/2015

Re: moxa1 post# 80506

Sunday, 04/09/2017 7:49:54 PM

Sunday, April 09, 2017 7:49:54 PM

Post# of 203913
I have my concerns that Sessions is going to make an example out of some people in a few states. Longer term, as soon as pharma starts getting FDA approval for various drugs that doctors can then describe for anything they want at their discretion, virtually all the non-FDA approved drugs are going to go away. The reason being is FDA drugs will be cheaper, covered by insurance and prescribed by doctors for liability reasons.

Any company not seeking to get FDA approved drugs in the long term are risking being left out.

As far as saying marijuana is a harmless drug is completey untrue. All you have to do is google studies that show there are those at risk for psychotic reactions if they are genetically predisposed. That's part of the reason why most companies are staying away from drugs taken orally. It's little known but there were a couple of companies who stopped Phase III clinical trials 20 years ago because of the psychoactive effects. I believe one of them was Valeant.